Rigel Pharmaceuticals | Beneficio Operativo



Operating Profit Cambio Fecha
Amgen USD 1.29B 1.02B 2025-03
Arrowhead Research USD 381.2M 542.61M 2025-03
AstraZeneca USD 3.67B 1.64B 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Celldex Therapeutics USD -62739000 6.71M 2025-03
Daiichi Sankyo JPY 83.61B 22.2B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Halozyme Therapeutics USD 141.54M 33.97M 2025-03
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
Ligand Pharmaceuticals USD -36216000 26.58M 2025-03
MacroGenics USD -16587000 70.78M 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Ultragenyx Pharmaceutical USD -142939000 20.66M 2025-03
Veracyte USD 1.16M 3.01M 2025-03



Rigel Pharmaceuticals Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jul 2025.